Article Results (Showing 1 - 10 of 15) RSS Alert
-
For social media, old media rules apply, say experts
PHARMAS spooked by the recent warning letter on an Adderall XR YouTube video shouldn't shy away from social media, according to industry regulatory...
Medical Marketing and Media, 11/01/08 by Comer, Ben · More from publication -
Heart risk in ADHD drugs?

Millions of children taking drugs for attention deficit hyperactivity disorder should be checked for heart problems, the American Heart Association...
Philadelphia Inquirer, The, 04/22/08 by Josh Goldstein Inquirer Staff Writer · More from publication -
Shire expanding Chesco footprint

Shire Pharmaceuticals Group P.L.C. is expanding its U.S. headquarters in Tredyffrin to support its growing pipeline of specialty drugs for rare...
Philadelphia Inquirer, The, 07/19/07 by Joseph Galante Inquirer Staff Writer · More from publication -
Shire to Buy Out Partner

One equity analyst jokingly called it ransom - at a fair price. Shire P.L.C., the No. 1 maker of attention-deficit medications with U.S....
Philadelphia Inquirer, The, 02/21/07 by Thomas Ginsberg · More from publication -
SHIRE PLC - Shire sues Andrx Pharmaceuticals, L.L.C.

Shire sues Andrx Pharmaceuticals, L.L.C. Basingstoke, UK and Philadelphia, US - November 10, 2006 - Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX:...
PR Newswire UK Disclose, 11/10/06 · More from publication -
Shire Sues Andrx Pharmaceuticals, L.L.C.

BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, November 10 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announces that...
PR Newswire Europe, 11/10/06 · More from publication -
Drugmaker Shire reports 19% rise in 3d-quarter revenue

Shire P.L.C. yesterday reported a 19 percent rise in third-quarter revenue as it continues to expand its share of the U.S. market for attention...
Philadelphia Inquirer, The, 10/28/06 by Linda Loyd · More from publication -
Shire revenue rose 19% as share of ADHD market grows

Shire P.L.C. today reported a 19 percent rise in third-quarter revenue as it continues to expand its share of the U.S. market for attention deficit...
Philadelphia Inquirer, The, 10/27/06 by Linda Loyd · More from publication -
ADDERALL XR(R) - Paragraph IV Notice Received.

BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, October 3 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) - Shire plc...
PR Newswire Europe, 10/03/06 · More from publication -
SHIRE PLC - ADDERALL XR Paragraph IV notice received.

ADDERALL XRA' - Paragraph IV notice received Basingstoke, UK and Philadelphia, US - October 03, 2006 - Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX:...
PR Newswire UK Disclose, 10/03/06 · More from publication



